Eduardo Uribe, MD
Hospitalist · San Antonio, TXNPI 1518970904
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. E.r. Squibb & Sons, L.L.C. accounts for 90.5% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for hospitalist clinicians in TX, where the typical reported total is $125.
Across 2 payments — averaging $69.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$125
- Aspira Women's Health Inc$13
Across 8 payments — averaging $16,622 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$111K
- Amgen$22K
What the payments were for
- Food & beverage$138100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Aspira Women's Health Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$125
How this compares
$138 in reported general payments places this provider in the 50th percentile of 1,284 hospitalist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 35 | $17,301 |
| FarxigaDapagliflozin Propanediol | 19 | $10,855 |
| GemtesaVibegron | 11 | $4,957 |
| Divalproex Sodium | 18 | $662 |
| Levothyroxine Sodium | 95 | $637 |
| Rosuvastatin Calcium | 37 | $624 |
| Atorvastatin Calcium | 99 | $563 |
| Pantoprazole Sodium | 36 | $516 |
| Memantine Hcl | 12 | $511 |
| NitrofurantoinNitrofurantoin Macrocrystal | 17 | $409 |
| ClopidogrelClopidogrel Bisulfate | 34 | $376 |
| Tamsulosin Hcl | 48 | $284 |
| Losartan Potassium | 36 | $277 |
| Lisinopril | 30 | $248 |
| Montelukast Sodium | 13 | $245 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in San Antonio
- Mubeen CheemaSan Antonio$50K
- Tarek HammadSan Antonio$42K
- Hendre FichardtSan Antonio$36K
- Sadie Trammell VelasquezSan Antonio$36K
- Justin Lee HalootSan Antonio$23K
- Salim RezaieSan Antonio$21K
- Amir Ashkan Ahmadian TehraniSan Antonio$18K
- Peter StawinskiSan Antonio$6K
- Terry LundSan Antonio$5K
- Chirag BuchSan Antonio$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.